ASX - By Stock
|
KEY |
Re:
News: KEY Key Petroleum Posts Half Year Loss Of A$2.586 Million
|
|
aabebi
|
24 |
13K |
2 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
24
|
13K
|
2
|
|
ASX - By Stock
|
MLS |
Re:
Ann: Quarterly Activities Report
|
|
aabebi
|
63 |
22K |
23 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
63
|
22K
|
23
|
|
ASX - By Stock
|
PGY |
Re:
Ann: Extension of Voluntary Suspension
|
|
aabebi
|
43 |
15K |
2 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
43
|
15K
|
2
|
|
ASX - By Stock
|
PGY |
Re:
Ann: Extension of Voluntary Suspension
|
|
aabebi
|
43 |
15K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
43
|
15K
|
2
|
|
ASX - By Stock
|
MLS |
Re:
Ann: Metallurgical Testing Confirms Lac Rainy High Purity / Grade
|
|
aabebi
|
154 |
33K |
17 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
154
|
33K
|
17
|
|
ASX - By Stock
|
CTV |
Re:
Ann: May 2020 Mid-Month Trading Update
|
|
aabebi
|
179 |
26K |
7 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
179
|
26K
|
7
|
|
ASX - By Stock
|
AQX |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
aabebi
|
2 |
1.8K |
8 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
2
|
1.8K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
KITE PHARMA mimic.
|
|
aabebi
|
15 |
12K |
9 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
15
|
12K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
valuation 2020
|
|
aabebi
|
62 |
135K |
10 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
62
|
135K
|
10
|
|
ASX - By Stock
|
IMU |
Conference next week
|
|
aabebi
|
2 |
1.9K |
5 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
2
|
1.9K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Latest Email from Leslie (11 Feb 2020 @ 9am)
|
|
aabebi
|
94 |
117K |
22 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
94
|
117K
|
22
|
|
ASX - By Stock
|
IMU |
Coronavirus
|
|
aabebi
|
7 |
12K |
6 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
7
|
12K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Share Placement to raise $24.6 million
|
|
aabebi
|
132 |
75K |
1 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
132
|
75K
|
1
|
|
ASX - By Stock
|
MLS |
Re:
Ann: Final Hole Intersects Wide Zone of High-Grade Graphite
|
|
aabebi
|
167 |
75K |
6 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
167
|
75K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Her-Vaxx 1b Update coming - ESMO 2019
|
|
aabebi
|
59 |
29K |
2 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
59
|
29K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI
|
|
aabebi
|
77 |
36K |
7 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
77
|
36K
|
7
|
|
ASX - By Stock
|
GTG |
Re:
GTGs biggest problem
|
|
aabebi
|
5 |
3.4K |
2 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
5
|
3.4K
|
2
|
|
ASX - By Stock
|
GTG |
US pre-market
|
|
aabebi
|
6 |
3.0K |
9 |
10/05/19 |
10/05/19 |
ASX - By Stock
|
6
|
3.0K
|
9
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Operational Update & Appendix 4C
|
|
aabebi
|
11 |
4.2K |
3 |
01/05/19 |
01/05/19 |
ASX - By Stock
|
11
|
4.2K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Leading Global Pharmaceutical Executive Joins Imugene Board
|
|
aabebi
|
77 |
29K |
1 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
77
|
29K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Leading Global Pharmaceutical Executive Joins Imugene Board
|
|
aabebi
|
77 |
29K |
12 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
77
|
29K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Presentation
|
|
aabebi
|
61 |
31K |
4 |
06/04/19 |
06/04/19 |
ASX - By Stock
|
61
|
31K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Presentation
|
|
aabebi
|
61 |
31K |
8 |
04/04/19 |
04/04/19 |
ASX - By Stock
|
61
|
31K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
|
|
aabebi
|
96 |
44K |
6 |
01/04/19 |
01/04/19 |
ASX - By Stock
|
96
|
44K
|
6
|
|
ASX - By Stock
|
IMU |
Wake up
|
|
aabebi
|
3 |
1.7K |
9 |
28/03/19 |
28/03/19 |
ASX - By Stock
|
3
|
1.7K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx
|
|
aabebi
|
32 |
14K |
9 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
32
|
14K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
|
|
aabebi
|
96 |
44K |
9 |
14/03/19 |
14/03/19 |
ASX - By Stock
|
96
|
44K
|
9
|
|
ASX - By Stock
|
IMU |
This will double
|
|
aabebi
|
3 |
2.5K |
12 |
07/03/19 |
07/03/19 |
ASX - By Stock
|
3
|
2.5K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Announces Presentation on HER-Vaxx at the AACR 2019
|
|
aabebi
|
12 |
7.0K |
4 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
12
|
7.0K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Pause in Trading
|
|
aabebi
|
23 |
10K |
4 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
23
|
10K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
A cure for cancer?
|
|
aabebi
|
12 |
5.3K |
1 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
12
|
5.3K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Announces Presentation on HER-Vaxx at the AACR 2019
|
|
aabebi
|
12 |
7.0K |
8 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
12
|
7.0K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
New investor pres with B-vaxx update
|
|
aabebi
|
36 |
21K |
7 |
27/02/19 |
27/02/19 |
ASX - By Stock
|
36
|
21K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Hard to believe?
|
|
aabebi
|
140 |
62K |
16 |
24/02/19 |
24/02/19 |
ASX - By Stock
|
140
|
62K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
Great News
|
|
aabebi
|
52 |
23K |
1 |
05/02/19 |
05/02/19 |
ASX - By Stock
|
52
|
23K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Great News
|
|
aabebi
|
52 |
23K |
6 |
05/02/19 |
05/02/19 |
ASX - By Stock
|
52
|
23K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Appendix 4C - quarterly
|
|
aabebi
|
43 |
21K |
1 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
43
|
21K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
BD1 Outlook
|
|
aabebi
|
524 |
222K |
2 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
524
|
222K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Goetzpartners
|
|
aabebi
|
18 |
10K |
5 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
18
|
10K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
aabebi
|
629 |
255K |
1 |
03/04/18 |
03/04/18 |
ASX - By Stock
|
629
|
255K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with MSD
|
|
aabebi
|
125 |
67K |
21 |
23/03/18 |
23/03/18 |
ASX - By Stock
|
125
|
67K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with MSD
|
|
aabebi
|
125 |
67K |
4 |
12/03/18 |
12/03/18 |
ASX - By Stock
|
125
|
67K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
overnight news from USA
|
|
aabebi
|
569 |
226K |
7 |
12/12/17 |
12/12/17 |
ASX - By Stock
|
569
|
226K
|
7
|
|
ASX - By Stock
|
DRK |
Company
|
|
aabebi
|
3 |
2.3K |
2 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
3
|
2.3K
|
2
|
|
ASX - By Stock
|
AGO |
Negative People
|
|
aabebi
|
67 |
24K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
67
|
24K
|
3
|
|
ASX - By Stock
|
AGO |
Under priced
|
|
aabebi
|
10 |
4.2K |
14 |
30/08/17 |
30/08/17 |
ASX - By Stock
|
10
|
4.2K
|
14
|
|
ASX - By Stock
|
AQC |
Positive Futre
|
|
aabebi
|
0 |
766 |
3 |
06/07/17 |
06/07/17 |
ASX - By Stock
|
0
|
766
|
3
|
|
ASX - By Stock
|
DRK |
30 cent shares
|
|
aabebi
|
12 |
6.1K |
1 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
12
|
6.1K
|
1
|
|
ASX - By Stock
|
CNX |
Re:
Ann: Consolidation/Split - CNX
|
|
aabebi
|
17 |
12K |
0 |
17/06/17 |
17/06/17 |
ASX - By Stock
|
17
|
12K
|
0
|
|
ASX - By Stock
|
WFL |
Re:
Ann: Appendix 4C - March 2017 Quarter
|
|
aabebi
|
422 |
145K |
15 |
28/04/17 |
28/04/17 |
ASX - By Stock
|
422
|
145K
|
15
|
|